Publications &
Presentations

July 2022
CRS 2022 Annual Meeting & Expo

OLAR®: A Novel Oral Long Acting Release (OLAR®) platform
Menashe Levy

Learn More
OLAR®
May 2022
IAPRD Congress 2022

Sleep problems in Parkinson’s Disease: PD patients’ survey on common issues and treatments expectations
Elijahu Berkovich, PhD

Learn More
CLE
600
October 2021
International Forum for the Study of Itch (IFSI) World Congress on Itch

CLE-400 for Chronic Neuropathic Itch
Yael Rosen, MD

Watch Video
CLE
400
September 2021
International Parkinson and Movement Disorder Society (MDS)

CLE-600: Treating nocturnal and early morning OFF symptomology in Parkinson's disease with the OLAR platform Elijahu Berkovich, PhD

Learn More
CLE
600
June 2021
International Association for the Study of Pain (IASP) 2021 Virtual World Congress on Pain

CLE 400 a potent alpha 2 adrenergic receptor agonist for the treatment of chronic itch
Elanite Caspi, PhD

Learn More
CLE
400
June 2021
International Association for the Study of Pain (IASP)

CLE-400 a Potent Analgesic Topical Gel in Acute and Chronic Pain Pig Models.
Elanite Caspi, PhD

Learn More
CLE
400
May 2021
Society for Investigative Dermatology (SID)

CLE-400 a potent alpha 2 adrenergic receptor agonist for the treatment of chronic itch
Johanna Schumann, PhD

Learn More
CLE
400
May 2021
International Association of Parkinsonism and Related Disorders (IAPRD)

CLE-600: Treating nocturnal and early morning OFF symptomology in Parkinson’s disease with the OLAR® platform
Elijahu Berkovich, PhD

Learn More
CLE
600
May 2021
SMi - 21st Annual Conference Pain Therapeutics - Virtual

CLE-400 a novel non-opioid topical treatment for painful diabetic neuropathy
Orna Goren, PhD

Learn More
CLE
400
March 2021
Drug Delivery & Formulation (DDF) Summit

Introducing the OLAR platform
Elijahu Berkovich, PhD

Learn More
OLAR®
Skip to content